Published in Rheumatol Int on January 30, 2015
Disability of Musculoskeletal Origin in Community-dwelling Elderly (DIME) | NCT00311103
Physical activity and cardiovascular health. NIH Consensus Development Panel on Physical Activity and Cardiovascular Health. JAMA (1996) 4.89
Home visits to prevent nursing home admission and functional decline in elderly people: systematic review and meta-regression analysis. JAMA (2002) 4.75
The measurement of hospital output. Int J Epidemiol (1972) 4.53
Restricted activity among community-living older persons: incidence, precipitants, and health care utilization. Ann Intern Med (2001) 4.25
Noncommunicable diseases. N Engl J Med (2013) 4.17
Recovery from disability among community-dwelling older persons. JAMA (2004) 3.85
Relative importance of musculoskeletal disorders as a cause of chronic health problems, disability, and health care utilization: findings from the 1990 Ontario Health Survey. J Rheumatol (1994) 3.12
The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups. Arthritis Rheum (1995) 2.58
The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis (2001) 2.50
Risk factors and precipitants of long-term disability in community mobility: a cohort study of older persons. Ann Intern Med (2012) 2.27
Widespread musculoskeletal pain and the progression of disability in older disabled women. Ann Intern Med (2001) 1.89
Factors associated with recovery of independence among newly disabled older persons. Arch Intern Med (2005) 1.47
Evaluating the risk of dependence in activities of daily living among community-living older adults with mild to moderate cognitive impairment. J Gerontol A Biol Sci Med Sci (1995) 1.45
A randomized study of a multidisciplinary program to intervene on geriatric syndromes in vulnerable older people who live at home (Dutch EASYcare Study). J Gerontol A Biol Sci Med Sci (2008) 1.30
The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis (2014) 1.29
The effectiveness and efficiency of home-based nursing health promotion for older people: a review of the literature. Med Care Res Rev (2006) 1.27
Activities of daily living function and disability in older adults in a randomized trial of the health enhancement program. J Gerontol A Biol Sci Med Sci (2004) 1.05
Prognostic effect of prior disability episodes among nondisabled community-living older persons. Am J Epidemiol (2003) 0.98
Profile of arthritis disability. Public Health Rep (2001) 0.96
A randomized trial of a screening, case finding, and referral system for older veterans in primary care. J Am Geriatr Soc (2007) 0.96
Prevalence and correlates of musculoskeletal pain in Chinese elderly and the impact on 4-year physical function and quality of life. Public Health (2009) 0.94
The conservative management of rotator cuff disorders. Br J Rheumatol (1994) 0.93
Exercise-based cardiac rehabilitation for very old patients (> or =75 years): focus on physical function. J Cardiopulm Rehabil Prev (2008) 0.90
Musculoskeletal work disability for clinicians: time course and effectiveness of a specialized intervention program by diagnosis. Arthritis Rheum (2007) 0.90
Impact of rheumatic diseases and chronic joint symptoms on quality of life in the elderly. Arch Gerontol Geriatr (2011) 0.85
A health system program to reduce work disability related to musculoskeletal disorders. Ann Intern Med (2005) 0.84
Prevalence and factors associated with rheumatic diseases and chronic joint symptoms in the elderly. Geriatr Gerontol Int (2013) 0.82
[Incidence of the onset of disability and recovery of functional autonomy among the very old after one year]. Rev Epidemiol Sante Publique (2000) 0.81
Incidence of physical disability related to musculoskeletal disorders in the elderly: results from a primary care-based registry. Arthritis Care Res (Hoboken) (2015) 0.80
Responsiveness of mobility, daily living, and instrumental activities of daily living outcome measures for geriatric rehabilitation. Arch Phys Med Rehabil (2010) 0.80
Interventions to prevent disability in frail community-dwelling older persons: an overview. Eur J Ageing (2010) 0.78
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum (2003) 5.29
High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet (2012) 4.46
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum (2010) 2.88
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period. Arthritis Res Ther (2006) 2.48
Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. J Rheumatol (2004) 2.20
Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists. Ann Rheum Dis (2010) 1.87
Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum (2007) 1.80
Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis Rheum (2007) 1.74
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis (2010) 1.63
Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.49
EpiReumaPt- the study of rheumatic and musculoskeletal diseases in Portugal: a detailed view of the methodology. Acta Reumatol Port (2015) 1.43
Burden of disease across chronic diseases: a health survey that measured prevalence, function, and quality of life. J Rheumatol (2007) 1.43
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis (2013) 1.39
Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease. Semin Arthritis Rheum (2008) 1.38
Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Rheum (2003) 1.36
Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population. Semin Arthritis Rheum (2007) 1.22
Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. Hum Mol Genet (2012) 1.17
Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project. Ann Rheum Dis (2013) 1.10
Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis. Ann Rheum Dis (2013) 1.09
Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity (2006) 1.09
Epidemiology of hip fracture in the elderly in Spain. Bone (2007) 1.05
Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum (2009) 1.04
Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis (2013) 1.04
Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis. Semin Arthritis Rheum (2013) 1.02
Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis. Semin Arthritis Rheum (2010) 1.00
Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases. Arthritis Care Res (Hoboken) (2013) 0.99
Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0. Ann Rheum Dis (2011) 0.98
Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis. J Rheumatol (2003) 0.98
Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis Rheumatol (2015) 0.97
A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis. Arthritis Rheum (2011) 0.97
Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry. Rheumatology (Oxford) (2011) 0.93
Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis. Rheumatology (Oxford) (2011) 0.93
Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol. Arthritis Rheum (2006) 0.92
Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry. Med Clin (Barc) (2011) 0.91
Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort. Arthritis Res Ther (2008) 0.90
Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis. J Rheumatol (2011) 0.90
Prognostic factors in short-term disability due to musculoskeletal disorders. Arthritis Rheum (2008) 0.90
Musculoskeletal work disability for clinicians: time course and effectiveness of a specialized intervention program by diagnosis. Arthritis Rheum (2007) 0.90
[Reduction in time until first treatment with disease modifying treatment in patients with rheumatoid arthritis]. Reumatol Clin (2008) 0.89
Effectiveness of a clinical practice intervention in early rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 0.88
Evidence for PTPN22 R620W polymorphism as the sole common risk variant for rheumatoid arthritis in the 1p13.2 region. J Rheumatol (2011) 0.87
Variability in resource consumption in patients with spondyloarthritis in Spain. Preliminary descriptive data from the emAR II study. Reumatol Clin (2012) 0.87
Efficacy and safety of TNF antagonists in sarcoidosis: data from the Spanish registry of biologics BIOBADASER and a systematic review. Semin Arthritis Rheum (2012) 0.86
A model for the development and implementation of a national plan for the optimal management of early spondyloarthritis: the Esperanza Program. Ann Rheum Dis (2011) 0.86
Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Semin Arthritis Rheum (2009) 0.85
Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme. Rheumatology (Oxford) (2013) 0.85
A health system program to reduce work disability related to musculoskeletal disorders. Ann Intern Med (2005) 0.84
Denosumab for the treatment of osteoporosis: a systematic literature review. Reumatol Clin (2012) 0.84
Development and validation of a new disease activity index as a numerical sum of four variables in patients with early arthritis. Arthritis Care Res (Hoboken) (2013) 0.83
[Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients]. Reumatol Clin (2011) 0.83
Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis. Rheumatol Int (2014) 0.82
Weather conditions may worsen symptoms in rheumatoid arthritis patients: the possible effect of temperature. Reumatol Clin (2013) 0.81
Calcium supplementation and kidney stone risk in osteoporosis: a systematic literature review. Clin Exp Rheumatol (2012) 0.81
Incidence of physical disability related to musculoskeletal disorders in the elderly: results from a primary care-based registry. Arthritis Care Res (Hoboken) (2015) 0.80
Interleukin-1 inhibitors for acute gout. Cochrane Database Syst Rev (2014) 0.80
Prevalence of silent amyloidosis in RA and its clinical significance. J Rheumatol (2004) 0.80
Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review. Semin Arthritis Rheum (2010) 0.80
Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients. Arthritis Res Ther (2011) 0.80
Perceptions, attitudes and experiences of family caregivers of patients with musculoskeletal diseases: a qualitative approach. Reumatol Clin (2013) 0.80
An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study. J Clin Rheumatol (2011) 0.80
Effectiveness of an early cognitive-behavioral treatment in patients with work disability due to musculoskeletal disorders. Arthritis Rheum (2009) 0.80
Efficacy and safety of DMARDs in psoriatic arthritis: a systematic review. Clin Exp Rheumatol (2012) 0.80
Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review. Semin Arthritis Rheum (2011) 0.80
Despair on disparities. Ann Rheum Dis (2009) 0.80
Management of rheumatoid arthritis in Spain (emAR II). Clinical characteristics of the patients. Reumatol Clin (2012) 0.80
Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience. Rheumatol Int (2013) 0.80
[Biobadaser 2.0: analysis and trends in 2009]. Reumatol Clin (2010) 0.79
Prognostic factors for long-term work disability due to musculoskeletal disorders. Rheumatol Int (2011) 0.79
Motivations and objections to implement a spondyloarthritis integrated care pathway. A qualitative study with primary care physicians. Reumatol Clin (2012) 0.79
The practical value of biologics registries in Africa and Middle East: challenges and opportunities. Clin Rheumatol (2012) 0.79
Dietary supplements for chronic gout. Cochrane Database Syst Rev (2014) 0.79
Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy. J Rheumatol (2013) 0.79
[Characteristics of Paget's disease in Spain. Data from the National Paget's Register]. Reumatol Clin (2009) 0.78
Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0. Rheumatol Int (2014) 0.78
Rheumatoid arthritis: genetic variants as biomarkers of cardiovascular disease. Curr Pharm Des (2015) 0.78
Association of CD247 polymorphisms with rheumatoid arthritis: a replication study and a meta-analysis. PLoS One (2013) 0.78
Pattern of use and safety of non-steroidal anti-inflammatory drugs in rheumatoid arthritis patients. A prospective analysis from clinical practice. Reumatol Clin (2009) 0.78
Negative affect in systemic sclerosis. Rheumatol Int (2013) 0.77
[Appropriate use of non-steroidal anti-inflammatory drugs in rheumatology: guidelines from the Spanish Society of Rheumatology and the Mexican College of Rheumatology]. Reumatol Clin (2009) 0.77
Diagnostic and prognostic value of genetics in undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl (2011) 0.77
[Adverse Reactions Related to the Administration of TNF Inhibitors. Analysis of a Registry of Biologic Therapy]. Reumatol Clin (2008) 0.77
A meta-analysis of mortality in rheumatic diseases. Reumatol Clin (2012) 0.77
Tackling missing radiographic progression data: multiple imputation technique compared with inverse probability weights and complete case analysis. Rheumatology (Oxford) (2012) 0.77
Validation of a new objective index to measure spinal mobility: the University of Cordoba Ankylosing Spondylitis Metrology Index (UCOASMI). Rheumatol Int (2013) 0.77
Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation? Arthritis Care Res (Hoboken) (2015) 0.77
Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis. Rheumatol Int (2014) 0.77
High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis: A Cross Sectional and Case Control Analysis Within the SUN Cohort. Medicine (Baltimore) (2015) 0.77
[Systematic review: safety and efficacy of anti-TNF in elderly patients]. Reumatol Clin (2010) 0.77